Canada · Health Canada Drug Product Database

AREXVY

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 102891
DIN: 02540207
Form: Powder For Suspension
Company as listed by source: GLAXOSMITHKLINE INC
Source status: Marketed (2023-09-06)
Source last updated: 2026-06-19

Source-listed ingredients

RESPIRATORY SYNCYTIAL VIRUS PREFUSION F PROTEIN (RSVPREF3) — 120 MCG — per 0.5 ML

These values do not establish equivalence or a dose recommendation.

Packages

Package details are not available in this snapshot.

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →